Beiersdorf AG 2025 AR2
The report highlights Beiersdorf's performance in 2025, during which the company achieved organic sales growth of 2.4% to reach €9,852 million. A key milestone was the absolute reduction of greenhouse gas emissions by 33% compared to 2018, exceeding the company's 2025 target. Beiersdorf also introduced its revolutionary anti-aging ingredient Epicelline® to the mass market with the NIVEA CELLULAR Epigenetics launch. Additionally, the company laid the foundation stone for a new €139 million innovation center in Hamburg, scheduled to open in 2028.
Company: Beiersdorf AG
Sector: Consumer Staples
Country: Germany
Year: 2025
Type: AR2
Pages: 353
Back to company
Beiersdorf AG
Annual Report
The report highlights Beiersdorf's performance in 2025, during which the company achieved organic sales growth of 2.4% to reach €9,852 million. A key milestone was the absolute reduction of greenhouse gas emissions by 33% compared to 2018, exceeding the company's 2025 target. Beiersdorf also introduced its revolutionary anti-aging ingredient Epicelline® to the mass market with the NIVEA CELLULAR Epigenetics launch. Additionally, the company laid the foundation stone for a new €139 million innovation center in Hamburg, scheduled to open in 2028.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees